Chemical Management, Science and Research

Halides Chemicals Pvt. Ltd. - Combining Quality And Reliability In Every Formula

December 22, 2022

Halides Chemicals
Halides Chemicals Pvt. Ltd. was incorporated in the year 1995. The company was formed with a view in mind to provide quality Halo Succinimides for pharmaceutical as well as chemical industry.

Spotlight

Endocyte

Endocyte is a biopharmaceutical company developing targeted therapies for the treatment of cancer and other serious diseases. Endocyte uses its proprietary technology to create novel SMDCs and companion imaging diagnostics for personalized targeted therapies. The company's SMDCs actively target receptors that are over-expressed on diseased cells, relative to healthy cells. This targeted approach is designed to enable the treatment of patients with highly active drugs at greater doses, delivered more frequently and over longer periods of time than would be possible with the untargeted drug alone. The companion imaging diagnostics are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment.

OTHER WHITEPAPERS
news image

Specialty silicone components

whitePaper | May 6, 2022

For over 40 years, NuSil® has developed high-purity components for sophisticated silicone chemistries. Our deep expertise allows us to develop innovative chemistries that serve demanding requirements in multiple industries and applications.

Read More
news image

Digital Lifecycle Excellence in the Energy & Utilities Industry

whitePaper | July 12, 2021

Learn how to apply physical and digital assets to deliver top performance across all categories. Today, modern energy and utility companies are faced with the complex task of getting more value from their physical assets and supporting data to improve efficiency and reduce costs. Using a digital lifecycle excellence approach to organize and consolidate that data will provide opportunities to increase competitiveness across your organization.

Read More
news image

Ensuring Compliance with ASTM STANDARDS for Mechanical Testing of Plastics and Composites

whitePaper | June 24, 2022

The performance of CFRPs depends on the fiber strength, the filling ratio of the carbon fibers in the resin and the orientation of the carbon fibers. For these reasons, CFPRs exhibit highly anisotropic mechanical behavior. Specialized

Read More
news image

Assumptions to the Annual Energy Outlook 2022

whitePaper | March 12, 2022

The National Energy Modeling System (NEMS) Industrial Demand Module (IDM) estimates U.S. energy consumption by energy source (fuels and feedstocks) in the Annual Energy Outlook (AEO) for 15 manufacturing and 6 nonmanufacturing industries.

Read More
news image

What to Know When Conveying and Feeding Calcium Carbonate in Plastics Compounding

whitePaper | May 11, 2021

This paper outlines the importance of correct design of a conveying and feeding system for calcium carbonate in plastics compounding operations and how it is not a trivial proposition because of the number of variables that affect the flow and different powders.

Read More
news image

A Journey from Processing to Recycling of Multilayer Waste Films

whitePaper | June 8, 2022

Since the discovery of polyethylene and polypropylene during the 1950s, polymers materials have been become popular and they are widely used for many applications of our daily life.

Read More

Spotlight

Endocyte

Endocyte is a biopharmaceutical company developing targeted therapies for the treatment of cancer and other serious diseases. Endocyte uses its proprietary technology to create novel SMDCs and companion imaging diagnostics for personalized targeted therapies. The company's SMDCs actively target receptors that are over-expressed on diseased cells, relative to healthy cells. This targeted approach is designed to enable the treatment of patients with highly active drugs at greater doses, delivered more frequently and over longer periods of time than would be possible with the untargeted drug alone. The companion imaging diagnostics are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment.

Events